Apelo R A, Suplido A
Clin Ther. 1985;8(1):61-70.
One hundred twenty women completed 901 woman-months of birth control with a new triphasic oral contraceptive. No pregnancies occurred, and good cycle control was achieved. Spotting and breakthrough bleeding were minimal, and amenorrhea did not occur. Changes in body weight and blood pressure were not statistically significant. The triphasic compound was well tolerated. Headache and dizziness were frequent complaints during the initial cycles but tended to subside within a few months.
120名女性使用一种新型三相口服避孕药进行了901个女性月的避孕。未发生妊娠，且实现了良好的周期控制。点滴出血和突破性出血极少，且未出现闭经。体重和血压变化无统计学意义。这种三相复方制剂耐受性良好。头痛和头晕在最初几个周期是常见主诉，但几个月内往往会减轻。
